Iron Triangle Partners’s Idexx Laboratories IDXX Stock Holding History

Iron Triangle Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-76,025	Closed	-$42.2M	–	32
2023 Q4	$42.2M	Buy	+76,025	New	+$35.7M	5.46%	5
2023 Q2	–	Sell	-50,000	Closed	-$25M	–	27
2023 Q1	$25M	Buy	+50,000	New	+$23.9M	3.61%	15
2021 Q3	–	Sell	-50,000	Closed	-$31.6M	–	28
2021 Q2	$31.6M	Buy	50,000 +15,000	+43%	+$8.28M	3.25%	17
2021 Q1	$17.1M	Buy	+35,000	New	+$17.5M	2.18%	19

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Iron Triangle Partners's IDXX Position: Q1 2024 in Review

Iron Triangle Partners sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 76,025 shares — an estimated $42.2M sold.

Iron Triangle Partners first reported a position in IDXX in Q1 2021 and held it in 4 quarters. The position peaked at $42.2M in Q4 2023. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

Iron Triangle Partners reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
Iron Triangle Partners sold 76,025 Idexx Laboratories shares in Q1 2024, an estimated $42.2M.
Iron Triangle Partners first reported a position in Idexx Laboratories in Q1 2021 and held it in 4 quarters.
Iron Triangle Partners's Idexx Laboratories position peaked at $42.2M in Q4 2023.
1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Iron Triangle Partners's 13F filing for Q1 2024, filed 15 May 2024.